コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n with 4-methoxybenzyl alcohol (4-MBA, anise alcohol).
2 y metabolites (terpenes, phenolic compounds, alcohol).
3 (Au, Pt, and SiO(2)) and fuels (H(2)O(2) and alcohols).
4 onist, PF-5190457, when co-administered with alcohol.
5 and with greater access to takeaway food and alcohol.
6 tocytes in fueling the cGAS-IRF3 response to alcohol.
7 advanced polycyclic intermediate to form an alcohol.
8 utein and zeaxanthin, magnesium, copper, and alcohol.
9 is derived from polymerization of coniferyl alcohol.
10 nts, and assigning a new proton signal as an alcohol.
11 and reduced conditioned place preference for alcohol.
12 replacement therapy, and use of tobacco and alcohol.
13 e-membered and six-membered cyclic secondary alcohols.
14 ha-branched aldehydes with different allylic alcohols.
15 ucts to generate the corresponding diterpene alcohols.
16 not induced to an appreciable level by other alcohols.
17 reacting with CO(2) to produce aldehydes and alcohols.
18 native coupling, starting from 2-aminobenzyl alcohol/1-phenylethanol and diamine/diol, respectively,
19 re 3-methyl-1-butanol and eugenol, phenethyl alcohol, 2-phenethyl acetate, acetic, isobutyric, isoval
21 ysfunction was associated with fewer days of alcohol abstinence and also predicted greater number hea
22 daptations are affected by number of days of alcohol abstinence and whether they influence heavy drin
25 , metabolic and genetic diseases, as well as alcohol abuse can also influence both hepatic and cardio
27 nerally associated with tobacco consumption, alcohol abuse or both, whereas pharynx cancers are incre
29 ods identified treatment barriers including, alcohol abuse, family conflicts, and mental health issue
30 abetes mellitus; 2.22 (95% CI 1.58-3.11) for alcohol abuse; 2.37 (95% CI 1.53-3.68) for liver disease
31 we identify disulfiram, a drug for treating alcohol addiction, as an inhibitor of pore formation by
33 , INSIG2, LPL, MYB, NXPH1, PER2, TNFA), gene-alcohol (ALDH2, APOA5, APOC3, CETP, LPL), gene-smoking (
34 ibited a broad reaction scope with different alcohols, allowing primary and secondary alcohols to be
36 he sp(3) C-H alkylation of 9H-fluorene using alcohol and a Ru catalyst via the borrowing hydrogen con
40 survey, the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), we used structu
42 ondary alcohols including cyclic and acyclic alcohols and a wide variety of arylacetonitriles bearing
43 re class dependent with best performance for alcohols and acetates, moderate performance for ketones,
45 es was mainly observed in primary long chain alcohols and, to a minor extent, in long-chain wax ester
47 psychiatric vulnerability (e.g., marijuana, alcohol, and caffeine misuse, perceived stress, and impu
49 ocosahexaenoic acid, omega-3 fatty acid, and alcohol-and 3 nutrients were associated with increased r
51 l practice, particularly among patients with alcohol-associated or NASH-related cirrhosis and those n
52 dinating carbonyl-directed coupling of allyl alcohols at the C-4 position of indole derivatives under
53 pendent plasma-supported oxidation of benzyl alcohol, benzaldehyde and phenol in the presence of mole
54 nitroaniline derivatives, in the presence of alcohols, benzimidazoles can be obtained in 64-72% yield
55 a range of differentially substituted benzyl alcohols, benzylamines and aniline and can also be perfo
56 mined DNA methylation predictors of smoking, alcohol, body mass index, serum proteins, and cell propo
59 iators for the electrocatalytic oxidation of alcohols by an iridium amido dihyride complex (PNP)Ir(H)
60 almost all methods for the incorporation of alcohols by C-H oxidation require the use of the alcohol
62 -directed remote C-H activation reactions of alcohols, carboxylic acids, sulfonates, phosphonates, an
63 t the isomerization of epoxides into allylic alcohols catalyzed by supported Au nanoparticles proceed
68 r the simple 2-phenoxy-1-phenylethane or its alcohol congener, 2-phenoxy-1-phenylethanol, the benzyli
70 Although both arms reduced average grams of alcohol consumed per week from baseline to 6 and 12 mont
71 he patient should be asked about the current alcohol consumption (i.e. active vs. abstinence, determi
73 of education (P = 0.26), smoking (P = 0.11), alcohol consumption (P = 0.52), history of cardiovascula
74 ts enrolled between 2006 and 2010, we tested alcohol consumption (stratified by the Centers of Diseas
78 in the basolateral amygdala (BLA) decreased alcohol consumption and reduced conditioned place prefer
79 an important role of NBCn1 in regulation of alcohol consumption and sensitivity to alcohol-induced s
83 mechanisms that prompt or mitigate excessive alcohol consumption could be partly explained by metabol
84 f-report severe periodontitis was noted when alcohol consumption exceeding > 20 g/day for women and >
86 th psychiatric disorders, whereas aspects of alcohol consumption have shown stronger links to metabol
89 e association study-defined genomic risk for alcohol consumption is enriched for genes that are prefe
91 demonstrate that the genetic architecture of alcohol consumption only partially overlaps with the gen
95 haviour) and an independent causal effect of alcohol consumption when controlling for smoking (IVW OR
96 nce of associations of genetically predicted alcohol consumption with heart failure (OR, 1.00 [95% CI
97 smoking, body mass index, physical activity, alcohol consumption, Alternative Healthy Eating Index, a
98 67:TA was amplified by increasing adiposity, alcohol consumption, and genetic risk of fatty liver dis
99 family history of dementia, non-smoking, low alcohol consumption, depression, daytime somnolence, epi
100 s included in the models included; age, sex, alcohol consumption, IBS diagnosis, family history of ga
102 ialty, waist circumference, body mass index, alcohol consumption, tobacco smoking, and physical activ
103 wn of Lmo4 in the nucleus accumbens enhanced alcohol consumption, whereas knockdown in the basolatera
111 ly differed in terms of terpenes, esters and alcohols content, thus proving that the yeast-inoculatin
113 ymptoms and associated secondary outcomes of alcohol craving and mood, anxiety, and sleep disturbance
114 gloeosporioides) incidence, without inducing alcohol dehydrogenase activity, which suggests that coat
115 alphaA-crystallin or alphaB-crystallin with alcohol dehydrogenase or citrate synthase by applying th
116 : oxidation of retinol into retinaldehyde by alcohol dehydrogenases (ADHs) or retinol dehydrogenases
117 nes including two alkane monooxygenases, two alcohol dehydrogenases, two aldehyde dehydrogenases, a f
119 ed the role of microglia in a mouse model of alcohol dependence using a colony stimulating factor 1 r
120 study, using a well-established rat model of alcohol dependence, ex vivo electrophysiology and ISH, p
122 ion: Reduced cerebral mGluR5 availability in alcohol-dependent patients recovers during abstinence an
124 nds via catalytic beta-scission of aliphatic alcohol derivatives with both aryl and alkyl halides is
125 trand crosslinks caused by an endogenous and alcohol-derived metabolite, and identify an excision-ind
127 ter of behavioural factors (ie, tobacco use, alcohol, diet, physical activity, and sodium intake), me
129 n 2.17 (1.70-2.76), those reporting moderate alcohol drinking 1.76 (1.21-2.57), and those with increa
130 y the selective agonist pioglitazone reduces alcohol drinking and alcohol-seeking behavior in rats.
131 estradiol, E2) are associated with increased alcohol drinking by women and experimentally in rodents.
133 ring protracted withdrawal from intermittent alcohol drinking resulted in enhanced prefrontal cortex
136 ped from easily available benzylic secondary alcohols employing thiophenol-stabilized iodonium ion as
138 ere identified, quantified and classified as alcohols, esters, acids, aldehydes, lactones, phenols, h
139 ltilayer metalized (MET), and ethylene vinyl alcohol (EVOH) based pouches and stored at 25, 35 and 45
142 oltage optical mapping in intact hearts from alcohol-exposed or aged mice (where JNK2 is activated).
144 s mechanistic insights into how both chronic alcohol exposure and protracted withdrawal dysregulate 5
145 s are reported to be killed by developmental alcohol exposure because of activation of microglial imm
147 n alpha-defensin 5 (HD5) was orally given to alcohol-fed mice to test the therapeutic potential.
148 nistically, the dehydrogenation of secondary alcohol follows clean pseudo-first-order kinetics and ex
149 fic focus is placed on fatty acids and fatty alcohols for their natural availability, low toxicity, b
152 be highly selective for the formation of cis alcohol (>90%), irrespective of the size of the hydride
155 n amino acid, aromatic aldehyde, and primary alcohol in alkaline solutions under microwave-assisted c
157 density and viscosity of sorbitol as a sugar alcohol in the ([mmim](MeO)(2)PO(2)) ionic liquid (IL) w
161 and oxetanes yielding secondary and tertiary alcohols in excellent yields and regioselectivities.
162 ducts with lower molecular weight, such as n-alcohols in O(1) class and subsequently to n-fatty acids
166 c deficiency of AR (knockout mice) prevented alcohol-induced increase in harmful AR metabolites, toxi
167 Taken together, the study suggests that alcohol-induced PC alpha-defensin dysfunction is mediate
168 ckout mice revealed increased sensitivity to alcohol-induced sedation and developed tolerance to the
171 adjustment for potential covariates, ages at alcohol initiation (AAIs) of 18.1-29.0 years, 29.1-39.0
173 f GalphasDREADD in DMS dMSNs or iMSNs alters alcohol intake and observed that CNO-dependent activatio
174 udy provides evidence in support of limiting alcohol intake in adherence to the USDGA recommendations
177 mic risk stratification, and to test whether alcohol intake or body mass index interacts with polygen
178 ved regulatory mechanism linking anxiety and alcohol intake that might contribute to increased suscep
179 of abstinence period, and quantification of alcohol intake), and if the patient is an active drinker
180 d on deterrent health factors, like smoking, alcohol intake, cheese consumption and average systolic
181 p with low mental health index score and low alcohol intake, HRs (95% CIs) for all-cause mortality we
188 ow inositol levels in response to high blood alcohol levels support a mechanism of reversible osmolar
190 tion based setting, drinking high volumes of alcohol may contribute to the prevalence of sleep proble
192 race/ethnicity, education, income, smoking, alcohol, menopausal hormone therapy, and hysterectomy st
193 variant in ADH1B is associated with a higher alcohol metabolizing activity compared to the ancestral
196 ce subscale, and the secondary outcome, male alcohol misuse, by the Alcohol Use Disorders Identificat
198 noparticles is introduced into the polyvinyl alcohol networks, building hybrid hydrogel evaporators i
199 generated by direct homolytic activation of alcohol O-H bonds through a proton-coupled electron-tran
201 night may be related to the acute effects of alcohol on GABAergic systems that are associated with sl
203 signed in a 1:1 ratio to either abstain from alcohol or continue their usual alcohol consumption.
208 drink containing approximately 12 g of pure alcohol) per week and who had paroxysmal or persistent a
209 lure, myocardial infarction, thyrotoxicosis, alcohol, pericarditis, pulmonary embolism, and myocardit
210 cture, the as-obtained anisotropic polyvinyl alcohol/polyaniline hydrogel can work as a stretching/co
211 CMP, a combination of painful conditions and alcohol problems had the largest effect size on mortalit
212 subsequently reacts with mCPBA to afford the alcohol product and regenerate the aroyloxy radical.
213 mate homeostasis in the NA core of cocaine + alcohol rats relative to rats consuming cocaine alone, s
214 that there will be a dramatic rising tide of alcohol relapse, admissions for decompensated ALD, and a
215 s2642438 was associated with reduced risk of alcohol-related cirrhosis (adjusted odds ratio, 0.76; P=
216 052 was associated with an increased risk of alcohol-related cirrhosis (adjusted odds ratio, 1.30; P=
217 c associations with the risks for developing alcohol-related cirrhosis and HCC were determined using
218 gment our knowledge of mechanisms underlying alcohol-related cognitive/motor impairment and inform in
221 the identification of mechanisms underlying alcohol-related impairment as well as factors reinforcin
223 framework of how emotional dysregulation and alcohol-related microbiome dysbiosis could accelerate th
229 , hypertension, diagnoses including obesity, alcohol, sleep apnea, diabetes, chronic obstructive pulm
231 uction of GalA to the oxidation of the sugar alcohol sorbitol that has a higher reduction state compa
233 n of the catalytic dehydration of tert-butyl alcohol (TBA) used to probe the activities of OH groups
234 acid and target volatile compounds (esters, alcohols, terpenols, volatile acids and volatile phenols
236 iscuss the major contribution of obesity and alcohol to the ten most common cancers as well as measur
237 ent alcohols, allowing primary and secondary alcohols to be employed as nonhazardous and greener alky
238 he alpha-alkylation of nitriles with primary alcohols to selectively synthesize nitriles by a well-de
243 e are evident, some open questions regarding alcohol use and its consequences in the US population re
244 ed, novel brain regions that are involved in alcohol use and novel biomarkers of alcohol use need to
245 of the amygdala plays a significant role in alcohol use and other affective disorders; however, the
246 ce experience and recent suicidal behaviour, alcohol use and recent suicidal behaviour, illicit drug
247 le the increased health risks resulting from alcohol use are evident, some open questions regarding a
249 imitations of using quantitative measures of alcohol use as proxy measures for AUD, and we outline ho
250 18q23 in regulating neural connectivity and alcohol use behavior, potentially via dysregulated myeli
252 use of mortality in the United States, where alcohol use consistently increased over the last decades
253 e expression and hippocampal degeneration in alcohol use disorder (AUD) and other mental diseases is
254 ical and economic consequences of coexisting alcohol use disorder (AUD) in patients with cirrhosis, l
256 and palatable fluids.SIGNIFICANCE STATEMENT Alcohol use disorder (AUD) is a major health burden worl
259 n a multicenter observational study, 36 with alcohol use disorder (AUD), and 17 persons without AUD (
261 ms, autism spectrum disorder, psychosis, and alcohol use disorder compared with the control sample.
263 individuals who met criteria for a past-year alcohol use disorder had a psychiatric comorbidity, whil
264 in female mice suggests that treatments for alcohol use disorder in women may need to account for th
265 ents with alcoholic hepatitis, patients with alcohol use disorder, and nonalcoholic controls using fu
266 aptive responses to stress are a hallmark of alcohol use disorder, but the mechanisms that underlie t
267 ndence are key factors in the development of alcohol use disorder, which is a pervasive societal prob
272 tanding of the neurocircuitry that underlies alcohol use has improved, novel brain regions that are i
276 e ((18)F-FPEB) PET has revealed that chronic alcohol use leads to decreased limbic mGluR5 availabilit
281 fter adjustment for confounders were harmful alcohol use, 1.4 (0.9-2.0, p = 0.10) and obesity, 1.4 (0
283 s findings in the literature concerning age, alcohol use, and depression-related changes in brain vol
284 HCC risk was also higher in patients with alcohol use, older age, and infection with HCV genotype
287 on of carbonyl moieties to the corresponding alcohol using simply hydrazine hydrate has been consider
288 oxidation of primary and secondary aliphatic alcohols using a pair of flavin and dialkylthiourea cata
289 based copolymer molecule containing vanillyl alcohol (VA) that exhibits high sensitivity and specific
293 y or almost daily consumption of tobacco and alcohol were both significantly associated with increase
294 tions to produce enantioenriched homoallylic alcohols with a stereodefined trisubstituted alkene.
296 ronic, heavy use increases the likelihood of alcohol withdrawal symptoms and associated secondary out
297 These data support further evaluation of alcohol withdrawal symptoms as a prognostic indicator of
299 ting critically ill patients including pain, alcohol withdrawal syndrome, status epilepticus, and acu